APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM NEW
Total 13F shares
483,678
Share change
+483,678
Total reported value
$1,789,466
Price per share
$3.70
Number of holders
12
Value change
+$1,789,466
Number of buys
12

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q1 2020

As of 31 Mar 2020, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 483,678 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, Worth Venture Partners, LLC, BlackRock Inc., UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, ATLAS CAPITAL ADVISORS LLC, ROYAL BANK OF CANADA, and Parallel Advisors, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.